Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-25 6:10 pm Unchanged | 2026-06-17 | 13G | FULCRUM THERAPEUTICS INC FULC | EcoR1 Capital, LLC | 6,000,000 9.000% | 0 (Unchanged) | Filing History |
| 2026-06-25 5:51 pm Purchase | 2026-06-17 | 13G | FULCRUM THERAPEUTICS INC FULC | EcoR1 Capital, LLC | 6,000,000 9.000% | 6,000,000 (New Position) | Filing History |
| 2026-06-10 6:13 pm Purchase | 2026-06-03 | 13G | FULCRUM THERAPEUTICS INC FULC | TANG CAPITAL MANAGEMENT, LLC | 5,451,800 8.200% | 5,451,800 (New Position) | Filing History |
| 2026-05-15 4:36 pm Sale | 2026-03-31 | 13G | FULCRUM THERAPEUTICS INC FULC | Nantahala Capital Management, LLC | 3,050,040 4.580% | -1,727,872 (-36.16%) | Filing History |
| 2026-05-15 4:26 pm Purchase | 2026-03-31 | 13G | FULCRUM THERAPEUTICS INC FULC | TCG Crossover GP II, LLC | 5,250,000 7.900% | 250,000 (+5.00%) | Filing History |
| 2026-03-26 6:37 pm Sale | 2026-03-13 | 13G | FULCRUM THERAPEUTICS INC FULC | VANGUARD GROUP INC | 0 0.000% | -3,274,592 (Position Closed) | Filing History |
| 2026-02-17 4:29 pm Purchase | 2025-12-31 | 13G | FULCRUM THERAPEUTICS INC FULC | RA Capital Management, L.P. | 6,649,973 9.900% | 596,013 (+9.85%) | Filing History |
| 2025-12-10 4:44 pm Sale | 2025-12-08 | 13G | FULCRUM THERAPEUTICS INC FULC | RA Capital Management, L.P. | 6,053,960 11.200% | -4,175,139 (-40.82%) | Filing History |
| 2025-11-13 09:03 am Sale | 2025-09-30 | 13G | FULCRUM THERAPEUTICS INC FULC | Adage Capital Management, L.P. | 2,432,000 4.500% | -2,157,000 (-47.00%) | Filing History |
| 2025-10-17 6:40 pm Sale | 2025-09-30 | 13G | FULCRUM THERAPEUTICS INC FULC | BlackRock, Inc. BLK | 3,270,322 6.000% | -762,554 (-18.91%) | Filing History |
| 2025-08-12 09:01 am Purchase | 2025-06-30 | 13G | FULCRUM THERAPEUTICS INC FULC | Adage Capital Management, L.P. | 4,589,000 8.500% | 1,589,000 (+52.97%) | Filing History |
| 2025-05-02 5:33 pm Purchase | 2025-03-31 | 13G | FULCRUM THERAPEUTICS INC FULC | Suvretta Capital Management, LLC | 5,067,394 9.400% | 1,662,782 (+48.84%) | Filing History |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | FULCRUM THERAPEUTICS INC FULC | BlackRock, Inc. BLK | 4,032,876 7.500% | -1,542,440 (-27.67%) | Filing History |
| 2025-02-12 09:32 am Purchase | 2024-12-31 | 13G | FULCRUM THERAPEUTICS INC FULC | Adage Capital Management, L.P. | 3,000,000 5.560% | 3,000,000 (New Position) | Filing History |
| 2025-01-06 4:50 pm Purchase | 2024-12-27 | 13G | FULCRUM THERAPEUTICS INC FULC | Suvretta Capital Management, LLC | 3,404,612 6.300% | 2,221,821 (+187.85%) | Filing History |
| 2024-12-06 4:28 pm Sale | 2024-11-30 | 13G | FULCRUM THERAPEUTICS INC FULC | BlackRock, Inc. BLK | 5,575,316 10.300% | -131,304 (-2.30%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | FULCRUM THERAPEUTICS INC FULC | Nantahala Capital Management, LLC | 4,777,912 7.657% | 4,777,912 (New Position) | Filing History |
| 2024-11-14 4:25 pm Sale | 2024-09-30 | 13G | FULCRUM THERAPEUTICS INC FULC | Suvretta Capital Management, LLC | 1,182,791 2.200% | -4,336,090 (-78.57%) | Filing History |
| 2024-11-14 06:15 am Sale | 2024-09-30 | 13G | FULCRUM THERAPEUTICS INC FULC | RTW Investments, LP | 0 0.000% | -5,469,956 (Position Closed) | Filing History |
| 2024-11-12 3:51 pm Unchanged | 2024-09-30 | 13G | FULCRUM THERAPEUTICS INC FULC | VANGUARD GROUP INC | 3,274,592 5.240% | 0 (Unchanged) | Filing History |